Back
Cirrus Logic 10K Form
Sell
43
CRUS
Cirrus Logic
Last Price:
104.10
Seasonality Move:
5.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-02-06 | 10Q | CRUS/Cirrus Logic Quarterly |
| 2023-11-02 | 10Q | CRUS/Cirrus Logic Quarterly |
| 2023-08-03 | 10Q | CRUS/Cirrus Logic Quarterly |
| 2023-02-02 | 10Q | CRUS/Cirrus Logic Quarterly |
| 2022-11-01 | 10Q | CRUS/Cirrus Logic Quarterly |
| 2022-08-02 | 10Q | CRUS/Cirrus Logic Quarterly |
Receive CRUS News And Ratings
See the #1 stock for the next 7 days that we like better than CRUS
CRUS Financial Statistics
Sales & Book Value
| Annual Sales: | $1.79B |
|---|---|
| Cash Flow: | $5.49M |
| Price / Cash Flow: | 10.42 |
| Annual Sales: | $36.29 |
| Price / Book: | 2.83 |
Profitability
| EPS (TTM): | 5.90000 |
|---|---|
| Net Income (TTM): | $327.8M |
| Gross Margin: | $916.07M |
| Return on Equity: | 18.01% |
| Return on Assets: | 14.67% |
Cirrus Logic Earnings Forecast
Key Cirrus Logic Financial Ratios
- The Gross Profit Margin over the past 37 years for CRUS is 51.21%.
- The Selling, General & Administrative Expenses for CRUS have been equal to 8.06% of Gross Profit Margin.
- The Research & Development expenses have been 23.84% of Revenue.
- The Interest Expense is 0.33% of Operating Income.
- The Net Earning history of CRUS is 15.35% of Total Revenues.
- Per Share Earnings over the last 37 years have been positive in 21 years.
Cirrus Logic Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Semiconductors & Semiconductor Equipment |
| Sector: | Information Technology |
| Current Symbol: | CRUS |
| CUSIP: | 172755 |
| Website: | cirrus.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.34 |
| Quick Ratio: | 3.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 20.98 |
|---|---|
| Forward P/E Ratio: | 15.19 |
CRUS Technical Analysis vs Fundamental Analysis
Sell
43
Cirrus Logic (CRUS)
is a Sell
Is Cirrus Logic a Buy or a Sell?
-
Cirrus Logic stock is rated a Sell
The current Cirrus Logic [CRUS] share price is $102.79. The Score for CRUS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.